Results 201 to 210 of about 13,097,347 (378)
Identification of Functional Cellular Markers Related to Human Health, Frailty and Chronological Age
Human skin fibroblasts in vitro preserve the memory of age and health. ABSTRACT Aging leads to a decline in physiological reserves, an increase in age‐related diseases, reduced functional ability and a shortened healthspan. While molecular markers of chronological aging exist, their link to general health and intrinsic capacity (IC), a composite ...
Chloé Brodeau+21 more
wiley +1 more source
Ethanol‐induced Nrf2 suppression in the lung is mediated by AP‐1‐driven expression of miR‐144
Previously, we determined that ethanol suppresses Nrf2 and thereby inhibits antioxidant and immune defenses in the lung. Clinically, individuals with AUD are vulnerable to pneumonia and acute lung injury. In this new experimental study, we report that ethanol inhibits Nrf2 in rat lung cells via the induction of miR‐144 in a mechanism dependent on the ...
Viranuj Sueblinvong+4 more
wiley +1 more source
Effect of Amphotericin B and Clotrimazole on Lymphocyte Stimulation
Arne Tärnvik, S Ånséhn
openalex +1 more source
Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice [PDF]
C A Lyman+2 more
openalex +1 more source
Nearly all cases of cryptococcosis in koalas are caused by Cryptococcus gattii species complex. A rare case of meningitis due to Cryptococcus neoformans VNI/AFLP1 (abbreviated VNI) is described in a koala with nasal colonisation by both species complexes.
A Teh+6 more
wiley +1 more source
Effect of Amphotericin B and Rifampin Against Coccidioides immitis In Vitro and In Vivo
M. Huppert+5 more
openalex +1 more source
Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole [PDF]
Robert H.K. Eng+4 more
openalex +1 more source
A Trial of Itraconazole or Amphotericin B for HIV‐Associated Talaromycosis
T. Le+23 more
semanticscholar +1 more source
Summary Baseline risk factors for acute kidney injury (AKI) during chimeric antigen receptor T‐cell (CAR‐T) therapy are not well described. Hence, we evaluated the incidence and risk factors associated with AKI among patients undergoing CAR‐T for relapsed/refractory large B‐cell lymphoma. Among 155 patients, 28 (18%) developed AKI with a median time‐to‐
John Sharp+19 more
wiley +1 more source